Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
31 March-01 April, 2025
Plastics Recycling EUPlastics Recycling EU
Not Confirmed
Not Confirmed
01-02 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
31 March-01 April, 2025
Plastics Recycling EUPlastics Recycling EU
Industry Trade Show
Not Confirmed
01-02 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
25 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/kangpu-biopharmaceuticals-received-ind-approval-from-nmpa-for-kpg-818-to-treat-relapsedrefractory-multiple-myeloma-302384336.html
20 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/kangpu-completed-bridging-clinical-study-of-kpg-818-in-china-302254025.html
10 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/kangpu-biopharmaceuticals-to-present-results-from-phase-2a-of-kpg-818-in-sle-at-eular-2024-302168112.html
20 Feb 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/kangpu-biopharmaceuticals-to-present-preclinical-efficacy-data-of-kpg-818-in-crohns-disease-at-the-19th-congress-of-ecco-ind-application-for-phase-ii-in-progress-302064814.html
19 Mar 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/kangpu-completes-patient-enrollment-for-phase-iia-clinical-trial-of-kpg-818-in-sle-in-the-us-301775628.html
12 Jun 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/kangpu-announces-first-patient-dosed-in-the-us-phase-iia-clinical-trial-of-neomides-molecular-glue-kpg-818-in-systemic-lupus-erythematosus-301566187.html
ABOUT THIS PAGE